Within the hormone receptor subtypes, TNBC and HER2+ groups had higher proportions of NDRG1 high cases, whereas ER+ tumours showed an equal distribution of high and low NDRG1 expressions (Figure 1J). The gene discussed is NDRG1; the disease is neoplasm.